Trials / Completed
CompletedNCT03400020
Efficacy of Vitamin C Administration for the Prevention of Postpolypectomy Bleeding
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Ilam University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Postpolypectomy bleeding is the most common major complication following a colonoscopic polypectomy procedure. The incidence rate ranging from 0.3 to 6.1%. Several preventive methods such as detachable snare and adrenaline injection have been proposed in the management of postpolypectomy bleeding in large colonic polyps. It has been demonstrated that administration of ascorbic acid (vitamin C) in abdominal surgeries could reduce the blood loss during the procedure, operation time and days of hospitalization. So the investigators designed a prospective, randomized study to compares the efficacy of vitamin C administration with application of prophylactic clip and detachable snare in the prevention of postpolypectomy bleeding in large polyps.
Detailed description
In this prospective, randomized clinical trial, patients diagnosed with colon polyps with a diameter \> 10 mm will randomized to receive either a 500 mg vitamin C in normal saline injection or a normal saline injection 2 hours before polypectomy. This administration will continued for 3 days after polypectomoy. Postpolypectomy bleeding is defined either as (1) early: occurring either during an endoscopic procedure or immediately after as hematochezia within 24 h or (2) delayed: any bleeding event that occurring between day 2 and day 30 following the polypectomy procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ascorbic acid | Ascorbic acid 500 Mg in normal saline IV two hours before the operation and thereafter 500 mg in normal saline IV daily for three days. |
| OTHER | Normal Saline | Normal saline IV two hours before the operation and thereafter for three days. |
Timeline
- Start date
- 2018-01-28
- Primary completion
- 2018-09-30
- Completion
- 2018-09-30
- First posted
- 2018-01-17
- Last updated
- 2018-10-18
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03400020. Inclusion in this directory is not an endorsement.